TB-500

PRODUCT DESCRIPTION
Peptide Name: TB-500
 
RESEARCH SUMMARY
Accelerated muscle tissue repair.
Enhanced wound healing speed.
Reduced inflammation in joints.
Increased angiogenesis promote growth.
Improved connective tissue flexibility.
 
Chemical Name: Thymosin Beta 4
CAS Number: 77591-33-4
 
TB-500 is a synthetic version of a naturally occurring peptide present in virtually all human and animal cells. It is a potent regenerative peptide that functions by sequestering G-actin, which plays a vital role in cell structure and movement. Unlike many other growth factors, TB-500 has a very low molecular weight, allowing it to travel long distances through tissues. Research indicates that this peptide is significantly upregulated following tissue injury, acting as a primary signal to initiate the repair process by migrating cells to the site of damage to build new blood vessels and fibers.
 
Researched Benefits:
Tissue Repair: Studies suggest it promotes the migration of cells to injured areas to facilitate the repair of muscles, tendons, and ligaments.
Anti-Inflammatory: Research shows it can significantly reduce acute inflammation in damaged tissues and joints.
Angiogenesis: Investigated for its ability to promote the growth of new blood vessels, improving nutrient delivery to recovering areas.
Collagen Deposition: Observed to assist in the healthy deposition of collagen, helping to maintain flexibility and reduce scar tissue formation.
 
KIT INCLUDES:
1x Peptide Vial
1x 10ml Sterile Water
1x Reconstitution Kit
 
DISCLAIMER
SAHPRA DISCLAIMER: This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
RESEARCH USE ONLY: This product is sold strictly for laboratory research and analytical purposes. It is not for human or veterinary use.
 
RESEARCH STUDIES
Philp, D., and Kleinman, H.K. (2004). Thymosin beta 4: a multifunctional regenerative peptide. Wound Repair and Regeneration. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1067-1927.2004.0124s1.x
Sosne, G., et al. (2010). Thymosin beta 4: a novel corneal wound healing agent with anti-inflammatory properties. Experimental Eye Research. https://www.sciencedirect.com/science/article/pii/S001448351000034X
Malinda, K.M., et al. (1997). Thymosin beta 4 accelerates wound healing. Journal of Investigative Dermatology. https://www.jidonline.org/article/S0022-202X(15)40476-8/fulltext